Literature DB >> 7923872

Membrane-bound complement regulatory activity is decreased on vaccinia virus-infected cells.

L Baranyi1, N Okada, K Baranji, H Takizawa, H Okada.   

Abstract

Decay accelerating factor (DAF), membrane cofactor protein (MCP), complement receptor 1 and mouse Crry are cell surface-bound complement regulatory proteins capable of inhibiting C3 convertase activity on cell membranes, and therefore provide a substantial protection from attack by homologous complement activated either by the classical or by the alternative pathway. Decrease in complement regulatory activity might lead to spontaneous complement deposition and subsequent cell injury. MoAb 5I2 can inhibit the complement regulatory activity of molecules on rat cells, resulting in deposition of homologous complement. The antigen recognized by 5I2 MoAb in rats is homologous to mouse Crry. Fifteen to 20 h after infection with vaccinia virus, in vitro cultured KDH-8 rat hepatoma cells show a strong decrease in expression of Crry-like antigen, and proved to be sensitive to complement deposition when 1:5 diluted normal rat serum was added to the culture medium as a source of complement. Addition of complement to the cultured KDH-8 cells infected with a very low dose of vaccinia virus (1 plaque-forming unit (PFU)/1000 cells) substantially reduced spreading of virus infection in the cell culture, while inactivation of complement by heat or zymosan treatment abrogated the protective effect.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7923872      PMCID: PMC1534175          DOI: 10.1111/j.1365-2249.1994.tb06619.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  The purification fo four strains of poxvirus.

Authors:  W K JOKLIK
Journal:  Virology       Date:  1962-09       Impact factor: 3.616

2.  Species-specific inhibition by glycophorins of complement activation via the alternative pathway.

Authors:  H Okada; H Tanaka
Journal:  Mol Immunol       Date:  1983-11       Impact factor: 4.407

3.  Modification of membrane permeability in vaccinia virus-infected cells.

Authors:  L Carrasco; M Esteban
Journal:  Virology       Date:  1982-02       Impact factor: 3.616

Review 4.  The complement system: its importance in the host response to viral infection.

Authors:  R L Hirsch
Journal:  Microbiol Rev       Date:  1982-03

5.  Additional evidence for the augmented induction of tumor-specific resistance in vaccinia virus-primed mice by immunization with vaccinia virus-modulated syngeneic tumor cells.

Authors:  S Ueda; N Wakamiya; K S Wu; S Kato; H Fujiwara; T Hamaoka
Journal:  Biken J       Date:  1984-03

6.  Sensitization of human tumor cells to homologous complement by vaccinia virus treatment.

Authors:  H Okada; N Wakamiya; N Okada; S Kato
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

7.  The augmentation of tumor-specific immunity by virus help. II. Enhanced induction of cytotoxic T lymphocyte and antibody responses to tumor antigens by vaccinia virus-reactive helper T cells.

Authors:  Y Shimizu; H Fujiwara; S Ueda; N Wakamiya; S Kato; T Hamaoka
Journal:  Eur J Immunol       Date:  1984-09       Impact factor: 5.532

8.  A new approach in specific, active immunotherapy.

Authors:  M K Wallack; Z Steplewski; H Koprowski; E Rosato; J George; B Hulihan; J Johnson
Journal:  Cancer       Date:  1977-02       Impact factor: 6.860

9.  Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment.

Authors:  G Hiller; K Weber
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

Review 10.  Complement, viruses, and virus-infected cells.

Authors:  N R Cooper; G R Nemerow
Journal:  Springer Semin Immunopathol       Date:  1983
View more
  3 in total

Review 1.  Dynamic control of the complement system by modulated expression of regulatory proteins.

Authors:  Joshua M Thurman; Brandon Renner
Journal:  Lab Invest       Date:  2010-10-04       Impact factor: 5.662

2.  Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope.

Authors:  A Vanderplasschen; E Mathew; M Hollinshead; R B Sim; G L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

Review 3.  Transcriptional control of complement receptor gene expression.

Authors:  Brian K Martin
Journal:  Immunol Res       Date:  2007       Impact factor: 4.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.